Rapid Micro Biosystems (RPID)
(Delayed Data from NSDQ)
$3.37 USD
+0.15 (4.66%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $3.34 -0.03 (-0.89%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth D Momentum F VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
RPID 3.37 +0.15(4.66%)
Will RPID be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for RPID based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for RPID
Rapid Micro Biosystems, Inc. (RPID) Reports Q2 Loss, Misses Revenue Estimates
Artivion (AORT) Tops Q2 Earnings and Revenue Estimates
RPID: What are Zacks experts saying now?
Zacks Private Portfolio Services
908 Devices Inc. (MASS) Reports Q2 Loss, Tops Revenue Estimates
Thermo Fisher Scientific (TMO) Tops Q2 Earnings and Revenue Estimates
Rapid Micro Biosystems, Inc. (RPID) Reports Q1 Loss, Tops Revenue Estimates
Other News for RPID
Pocket Pivot appears for RPID after 4.66% move
RPID Crossed Above 50 Day Moving Average on September 18
RPID forms MACD Bullish Centerline Cross on September 17
RPID Fell Below 50 Day Moving Average on September 16
Is RPID likely to continue higher? Crossed Above 50 Day Moving Average shows up after rising 4.13%